Castle Creek Arbitrage’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Castle Creek Arbitrage’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,681	Closed	-$2.71K	–	564
2022 Q4	$2.71K	Buy	+10,681	New	+$2.15K	﹤0.01%	469

Castle Creek Arbitrage's EBACW Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 10,681 shares — an estimated $2.71K sold.

Castle Creek Arbitrage first reported a position in EBACW in Q4 2022 and held it in 1 quarter. The position peaked at $2.71K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Castle Creek Arbitrage reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 10,681 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $2.71K.
Castle Creek Arbitrage first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2022 and held it in 1 quarter.
Castle Creek Arbitrage's European Biotech Acquisition Corp. Warrant position peaked at $2.71K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.